IL6 and disease of the tendon: Furthermore, the molecular docking results presented the stable and high-affinity binding of NGR1 to TNF-α, IL-6, MMP3, MMP9, and MMP13, indicating that NGR1 may exert its therapeutic effects on tendinopathy by modulating inflammatory responses and cellular and extracellular matrix metabolism.